The AdvisorShares Pure US Cannabis ETF MSOS surged by more than 14% on Thursday as the whole cannabis sector experienced a boost of enthusiasm on news that the Department of Health and Human Services was officially directing the DEA to ease the onerous federal restrictions on cannabis and move it to a lower-risk category.
Leading The Pack
By the end of the day Thursday, MSOS was in the number-one spot for top-performing ETFs for the month of August, having gained more than 20% over the month.
Scott Redler, chief strategist T3Live/T3TradingGroup, pointed out that amid the red, the MSOS cannabis ETF looked wonderful in green.
lots of red in August - $MSOS woke up and took the lead pic.twitter.com/RvzRGV9f66
— Scott Redler (@RedDogT3) August 31, 2023
Some of Thursday's biggest winners include:
Trulieve Cannabis TCNNF shares closed up 29.61% at $5.69
Cresco Labs CRLBF shares closed up 27.42% at $1.58
MedMen Enterprises MMNFF shares closed up 26.29% at $0.02
Canopy Growth CGC shares closed up 25.76% at $0.57
C21 Investments CXXIF shares closed up 25.08% at $0.32
Curaleaf Holdings CURLF shares closed up 17.61% at $3.74
Tilray Brands TLRY shares closed up 11.28% at $2.96
Wild Ride
Keep up with how these shifting cannabis policy reforms will affect marijuana stocks.
To stay on top of the future of cannabis regulation, meet the CEOs of some of the above companies and speak with experts on how to invest wisely in this dynamic sector. Join us at the Benzinga Cannabis Capital Conference in Chicago on September 27-28.
Get your tickets today before prices go up and secure a spot at the epicenter of cannabis investment, culture, finance and branding.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.